Boothbay Fund Management LLC Sells 49,090 Shares of Encompass Health Co. (NYSE:EHC)

Boothbay Fund Management LLC lessened its position in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 67.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 23,869 shares of the company's stock after selling 49,090 shares during the period. Boothbay Fund Management LLC's holdings in Encompass Health were worth $2,204,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in the company. Miracle Mile Advisors LLC lifted its stake in shares of Encompass Health by 3.0% in the 4th quarter. Miracle Mile Advisors LLC now owns 3,835 shares of the company's stock valued at $354,000 after acquiring an additional 112 shares during the last quarter. US Bancorp DE grew its stake in shares of Encompass Health by 9.6% in the fourth quarter. US Bancorp DE now owns 1,380 shares of the company's stock worth $127,000 after purchasing an additional 121 shares during the last quarter. Signaturefd LLC lifted its holdings in Encompass Health by 21.6% during the 4th quarter. Signaturefd LLC now owns 704 shares of the company's stock worth $65,000 after buying an additional 125 shares during the period. CBIZ Investment Advisory Services LLC increased its stake in shares of Encompass Health by 38.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock valued at $42,000 after buying an additional 127 shares during the period. Finally, MassMutual Private Wealth & Trust FSB boosted its holdings in Encompass Health by 87.8% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock valued at $27,000 after acquiring an additional 137 shares during the last quarter. 97.25% of the stock is owned by institutional investors.

Analyst Ratings Changes

EHC has been the topic of several research analyst reports. StockNews.com upgraded Encompass Health from a "hold" rating to a "buy" rating in a research report on Friday, April 25th. Barclays lifted their target price on Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a report on Friday, April 25th. William Blair reiterated an "outperform" rating on shares of Encompass Health in a research report on Friday, February 7th. Royal Bank of Canada boosted their price target on shares of Encompass Health from $110.00 to $125.00 and gave the stock an "outperform" rating in a research note on Monday. Finally, UBS Group lifted their price objective on shares of Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a report on Monday. Nine investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Encompass Health presently has a consensus rating of "Buy" and an average target price of $120.86.

Encompass Health Stock Up 0.7 %

Shares of NYSE EHC traded up $0.79 during mid-day trading on Friday, hitting $116.73. 780,052 shares of the stock traded hands, compared to its average volume of 684,099. The stock has a fifty day moving average price of $101.41 and a 200-day moving average price of $99.09. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05. The company has a market cap of $11.76 billion, a price-to-earnings ratio of 26.17, a PEG ratio of 2.31 and a beta of 0.87. Encompass Health Co. has a 52 week low of $82.38 and a 52 week high of $121.39.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings results on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, topping the consensus estimate of $1.19 by $0.18. The company had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. During the same quarter in the prior year, the business posted $1.12 EPS. The firm's quarterly revenue was up 10.6% compared to the same quarter last year. Research analysts anticipate that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be issued a dividend of $0.17 per share. The ex-dividend date is Tuesday, July 1st. This represents a $0.68 annualized dividend and a dividend yield of 0.58%. Encompass Health's payout ratio is 14.05%.

Insider Buying and Selling

In other news, CAO Andrew L. Price sold 5,042 shares of the company's stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the sale, the chief accounting officer now owns 69,164 shares of the company's stock, valued at $6,798,129.56. This represents a 6.79 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP John Patrick Darby sold 10,000 shares of the business's stock in a transaction on Tuesday, April 29th. The shares were sold at an average price of $114.79, for a total transaction of $1,147,900.00. Following the sale, the executive vice president now directly owns 79,710 shares of the company's stock, valued at approximately $9,149,910.90. The trade was a 11.15 % decrease in their position. The disclosure for this sale can be found here. 2.10% of the stock is currently owned by corporate insiders.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.